Patents
The invention relates to a synergistic hepatoprotective pharmaceutical composition comprising an effective amount of trans-tetracos-15-enoic acid (TCA) and Apocynin (APO), the invention also relates to a method of treatment for hepatotoxicity in mammals and humans.